LABORATORIOS LIOMONT FDA Approval ANDA 205319

ANDA 205319

LABORATORIOS LIOMONT

FDA Drug Application

Application #205319

Application Sponsors

ANDA 205319LABORATORIOS LIOMONT

Marketing Status

Prescription001

Application Products

001TABLET;ORALEQ 10MG BASE0MONTELUKAST SODIUMMONTELUKAST SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2020-10-30STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

LABORATORIOS LIOMONT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205319
            [companyName] => LABORATORIOS LIOMONT
            [docInserts] => ["",""]
            [products] => [{"drugName":"MONTELUKAST SODIUM","activeIngredients":"MONTELUKAST SODIUM","strength":"EQ 10MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/30\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-10-30
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.